IROHW Financials
This page shows IROHW (IROHW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
IROHW passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.
For every $1 of reported earnings, IROHW generates $-0.74 in operating cash flow (-$1.0M OCF vs $1.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
IROHW reported $1.4M in net income in fiscal year 2024. This represents an increase of 545.5% from the prior year.
Cash & Balance Sheet
IROHW held $41.4M in cash against $0 in long-term debt as of fiscal year 2024.
IROHW had 48M shares outstanding in fiscal year 2024. This represents an increase of 2285.4% from the prior year.
Margins & Returns
IROHW's ROE was 12.7% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 30879212.7 percentage points from the prior year.
Capital Allocation
IROHW Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.9M | N/A | N/A | N/A | $4.3M | N/A | N/A | N/A |
| Cost of Revenue | $2.3M | N/A | N/A | N/A | $1.3M | N/A | N/A | N/A |
| Gross Profit | $5.6M | N/A | N/A | N/A | $2.9M | N/A | N/A | N/A |
| R&D Expenses | $38K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $438K | N/A | N/A | N/A | $509K | N/A | N/A | N/A |
| Operating Income | $4.6M+782.6% | -$672K-29.2% | -$520K | N/A | $2.3M+1063.7% | -$238K+50.3% | -$480K | N/A |
| Interest Expense | -$10K | N/A | N/A | N/A | -$9K | N/A | N/A | N/A |
| Income Tax | $1.4M+842.7% | $146K-2.0% | $149K | N/A | $744K+317.7% | $178K-15.7% | $211K | N/A |
| Net Income | $3.3M+14.5% | $2.9M+277.7% | $774K | N/A | $1.6M+339.1% | $357K+95056.8% | $375 | N/A |
| EPS (Diluted) | $0.07 | N/A | N/A | N/A | $0.04 | N/A | N/A | N/A |
IROHW Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $56.2M-23.3% | $73.3M-0.4% | $73.6M+45.1% | $50.8M-29.3% | $71.8M+1.1% | $71.0M+0.8% | $70.4M+1.0% | $69.7M |
| Current Assets | $46.2M+29690.9% | $155K+94.6% | $80K-99.8% | $44.0M+61636.8% | $71K-70.2% | $239K-56.0% | $544K-21.2% | $690K |
| Cash & Equivalents | $37.2M+147759.1% | $25K+28495.5% | $88-100.0% | $41.4M+1343377.7% | $3K-96.6% | $91K-49.0% | $179K-72.7% | $657K |
| Inventory | $1.9M | N/A | N/A | $1.3M | N/A | N/A | N/A | N/A |
| Accounts Receivable | $0 | N/A | N/A | $845 | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $38.5M-48.7% | $75.0M+20.9% | $62.0M+55.2% | $39.9M-36.2% | $62.6M-1.7% | $63.7M+0.4% | $63.5M-8.9% | $69.7M |
| Current Liabilities | $38.2M-47.3% | $72.4M+2056.4% | $3.4M-91.6% | $39.9M+2529.0% | $1.5M+25.7% | $1.2M+10.2% | $1.1M+27.3% | $862K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $17.7M+20.4% | $14.7M+26.7% | $11.6M+7.6% | $10.8M+18.5% | $9.1M+25.7% | $7.3M+4.6% | $6.9M+693567700.0% | $1 |
| Retained Earnings | $11.0M+280.5% | -$6.1M-26.0% | -$4.9M-221.4% | $4.0M+223.3% | -$3.2M-8.0% | -$3.0M-6.6% | -$2.8M-4.6% | -$2.7M |
IROHW Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.7M-123.0% | -$1.6M-300.7% | -$409K+98.2% | -$22.9M-202.6% | $22.3M+42233.0% | -$53K+85.9% | -$374K | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$1.7M-248.8% | $1.2M+1959.3% | -$62K-102.4% | $2.6M+191.8% | -$2.8M-281114700.0% | $1-100.0% | $3K | N/A |
| Financing Cash Flow | $35K-93.0% | $510K+8.3% | $471K-35.0% | $725K | $0+100.0% | -$35K+67.3% | -$107K | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
IROHW Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.4% | N/A | N/A | N/A | 68.7% | N/A | N/A | N/A |
| Operating Margin | 58.0% | N/A | N/A | N/A | 53.5% | N/A | N/A | N/A |
| Net Margin | 42.3% | N/A | N/A | N/A | 36.5% | N/A | N/A | N/A |
| Return on Equity | 18.9%-1.0pp | 19.8%+13.2pp | 6.7% | N/A | 17.2%+12.3pp | 4.9%+4.9pp | 0.0% | N/A |
| Return on Assets | 5.9%+2.0pp | 4.0%+2.9pp | 1.1% | N/A | 2.2%+1.7pp | 0.5%+0.5pp | 0.0% | N/A |
| Current Ratio | 1.21+1.2 | 0.00-0.0 | 0.02-1.1 | 1.10+1.1 | 0.05-0.2 | 0.20-0.3 | 0.50-0.3 | 0.80 |
| Debt-to-Equity | 2.17-2.9 | 5.09-0.2 | 5.33+1.6 | 3.69-3.2 | 6.87-1.9 | 8.78-0.4 | 9.15-999990.8 | 1000000.00 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
Is IROHW profitable?
Yes, IROHW (IROHW) reported a net income of $1.4M in fiscal year 2024.
What is IROHW's return on equity (ROE)?
IROHW (IROHW) has a return on equity of 12.7% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is IROHW's operating cash flow?
IROHW (IROHW) generated -$1.0M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are IROHW's total assets?
IROHW (IROHW) had $50.8M in total assets as of fiscal year 2024, including both current and long-term assets.
What is IROHW's current ratio?
IROHW (IROHW) had a current ratio of 1.10 as of fiscal year 2024, which is considered adequate.
What is IROHW's debt-to-equity ratio?
IROHW (IROHW) had a debt-to-equity ratio of 3.69 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is IROHW's return on assets (ROA)?
IROHW (IROHW) had a return on assets of 2.7% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is IROHW's cash runway?
Based on fiscal year 2024 data, IROHW (IROHW) had $41.4M in cash against an annual operating cash burn of $1.0M. This gives an estimated cash runway of approximately 491 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is IROHW's Piotroski F-Score?
IROHW (IROHW) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are IROHW's earnings high quality?
IROHW (IROHW) has an earnings quality ratio of -0.74x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.